SlideShare a Scribd company logo
1 of 31
Shock
• Shock is defined as circulatory insufficiency that
creates an imbalance between tissue oxygen
supply and oxygen demand.
• The result of shock is global tissue hypoperfusion
and is associated with a decreased venous oxygen
content and metabolic acidosis (lactic acidosis).
• Clinically, shock may have a predominant cause,
but as the shock state persists or progresses to
irreversible end organ damage, other
pathophysiologic mechanisms become operative
• Shock is classified into four categories by etiology
(1) hypovolemic (caused by inadequate circulating
volume)
(2) cardiogenic (caused by inadequate cardiac
pump function)
(3) distributive (caused by peripheral vasodilatation
and maldistribution of blood flow)
(4) obstructive (caused by extra cardiac obstruction
to blood flow).
Pathophysiology
• The onset of shock -- autonomic responses, many of which serve to
maintain perfusion pressure to vital organs.
• Stimulation of the carotid baroreceptor stretch reflex activates the
sympathetic nervous system leading to:
• (1) arteriolar vasoconstriction, resulting in redistribution of blood
flow from the skin, skeletal muscle, kidneys, and splanchnic viscera;
• (2) an increase in heart rate and contractility that increases cardiac
output;
• (3) constriction of venous capacitance vessels, which augments
venous return;
• (4) release of the vasoactive hormones epinephrine, norepinephrine,
dopamine, and cortisol to increase arteriolar and venous tone; and
• (5) release of antidiuretic hormone and activation of the reninangiotensin axis to enhance water and sodium conservation to
maintain intravascular volume.
• These compensatory mechanisms attempt to maintain DO2 to the most
critical organs—the coronary and cerebral circulation. During this
process, blood flow to other organs such as the kidneys and
gastrointestinal tract may be compromised.
• In the early phases of septic shock, these physiologic changes
produce a clinical syndrome called the systemic inflammatory
response syndrome or SIRS, defined as the presence of two or more
of the following features:
• (1) temperature greater than 38°C (100.4°F) or less than 36°C
(96.8°F);
• (2) heart rate faster than 90 beats/min;
• (3) respiratory rate faster than 20 breaths/min; and
• (4) white blood cell count greater than 12.0 x 109/L, less than 4.0 x
109/L, or with greater than 10 percent immature forms or bands.
• 5) As SIRS progresses, shock ensues, followed by multiorgan
dysfunction syndrome (MODS) manifested by myocardial
depression, adult respiratory distress syndrome, disseminated
intravascular coagulation, hepatic failure, or renal failure.
• The fulminate progression from SIRS to MODS is determined by the
balance of anti-inflammatory and proinflammatory mediators or
cytokines that are released from endothelial cell disruption
• The cellular response to decreased DO2 ( oxygen delivery
per minute ) is adenosine triphosphate depletion leading to
ion-pump dysfunction, influx of sodium, efflux of
potassium, and reduction in membrane resting potential.
Cellular edema occurs secondary to increased intracellular
sodium, while cellular membrane receptors become poorly
responsive to the stress hormones insulin, glucagon,
cortisol, and catecholamines. As shock progresses,
lysosomal enzymes are released into the cells with
subsequent hydrolysis of membranes, deoxyribonucleic
acid, ribonucleic acid, and phosphate esters. As the cascade
of shock continues, the loss of cellular integrity and the
breakdown in cellular homeostasis result in cellular death.
These pathologic events give rise to the metabolic features
of hemoconcentration, hyperkalemia, hyponatremia,
prerenal azotemia, hyper- or hypoglycemia, and lactic
acidosis.
ABCDE tenets of shock resuscitation
•
•
•
•
•

establishing Airway
controlling the work of Breathing
optimizing the Circulation
assuring adequate oxygen Delivery, and
achieving End points of resuscitation
Establishing Airway
• Airway control is best obtained through endotracheal
intubation for airway protection, positive pressure
ventilation (oxygenation), and pulmonary toilet.
Sedatives, which are frequently used to facilitate
intubation, can exacerbate hypotension through
arterial vasodilatation, venodilation, and myocardial
suppression. Furthermore, positive pressure ventilation
reduces preload and cardiac output. The combination
of these interventions can lead to hemodynamic
collapse. Volume resuscitation or application of
vasoactive agents may be required prior to intubation
and positive pressure ventilation.
Controlling the Work of Breathing
• Control of breathing is required when tachypnea accompanies
shock. Respiratory muscles are significant consumers of oxygen
during shock and contribute to lactate production. Mechanical
ventilation and sedation decrease the work of breathing and have
been shown to improve survival. SaO2 should be restored to greater
than 93 percent and ventilation controlled to maintain a PaCO2 35
to 40 mm Hg. Attempts to normalize pH above 7.3 by
hyperventilation are not beneficial. Mechanical ventilation not only
provides oxygenation and corrects hypercapnia but assists, controls,
and synchronizes ventilation, which ultimately decreases the work
of breathing. Neuromuscular blocking agents are used as adjuncts
to further decrease respiratory muscle, oxygen consumption and
preserve DO2 to vital organs
Optimizing the Circulation
• Circulatory or hemodynamic stabilization begins with intravascular access
through large-bore peripheral venous lines. Trendelenburg positioning,
historically considered necessary for maintaining perfusion in the
hypotensive patient, does not improve cardiopulmonary performance
compared with the supine position. It may worsen pulmonary gas
exchange and predispose to aspiration. If a volume challenge is urgently
required, rather than using the Trendelenburg position, an alternative is to
raise the patient's legs above the level of the heart with the patient
supine.
• Fluid resuscitation begins with isotonic crystalloid; the amount and rate
are determined by an estimate of the hemodynamic abnormality. Most
patients in shock have either an absolute or relative volume deficit, except
the patient in cardiogenic shock with pulmonary edema
• Vasopressor agents are used when there has been an inadequate
response to volume resuscitation or when a patient has contraindications
to volume infusion
Assuring Adequate Oxygen Delivery
• Once blood pressure is stabilized through
optimization of preload and afterload, DO2 can be
assessed and further manipulated. Arterial
oxygen saturation should be returned to
physiologic levels (93 to 95 percent) and
hemoglobin maintained above 10 g/dL.13 If
cardiac output can be assessed, it should be
increased by using volume infusion and inotropic
agents in incremental amounts until venous
oxygen saturation (SmvO2 or ScvO2) and lactate
are normalized.
Achieving End Points of Resuscitation
Hypovolemic shock
•
•

2 types
Hemorrhagic hypovolemia
–
–
–
–
–
–
–
–
–
–
–

–
–

Thorax
Pulmonary parenchymal trauma
Pulmonary vascular injury
Intercostal vascular injury
Aortic disruption
Massive hemoptysis
Abdomen/pelvis/retroperitoneum
Solid organ injuries (liver, spleen, kidney)
Vascular (trauma, aneurysmal rupture)
Gastrointestinal hemorrhage (esophageal
varices, ulcers, vascular anomalies, etc.)
Gynecologic disorders (ruptured ectopic
pregnancy, peripartum hemorrhage,
abnormal uterine bleeding, ovarian cyst
rupture, etc.)
Major vascular injuries
Large soft tissue injuries

• Non hemorrhagic hypovolemia
• Gastrointestinal
disorders: vomiting,
diarrhea, ascites
• Burns
• Environmental exposure
or neglect
• Renal salt wasting
Resuscitation Fluids
• Isotonic crystalloid
– Normal saline (NS)
– Lactated Ringer's (LR) solution
– Ringer's acetate

• Colloids
– Albumin: 5% and 25%
concentrations
– Fresh-frozen plasma
– Hetastarch: 6% hydroxyethyl
starch concentration
– Dextran -40 (molecular
weight 40 kDa) 10% solution
– Dextran -70 (molecular
weight 70 kDa) 6% solution
– Gelatin

• Hypertonic solutions
– Saline: 7.0 to 7.5% NaCl
– Saline and dextran: 7.5% NaCl
and 6% Dextran-70

• Oxygen carrying
resuscitation fluids
– Hemoglobin-based oxygen
carriers
– Fluorocarbon-based oxygen
carriers

• Blood
– Packed red blood cells
Cardiogenic shock
• Cardiogenic shock is defined as a state of
decreased cardiac output (CO) producing
inadequate tissue perfusion despite adequate
or excessive circulating volume.
• Clinical signs of cardiogenic shock include
evidence of poor CO with tissue
hypoperfusion (hypotension, mental status
changes, cool mottled skin) and evidence of
volume overload (dyspnea,
Causes
• Acute myocardial infarction
• Pump failure
– Mechanical complications
– Acute mitral regurgitation
secondary to papillary muscle
rupture
– Ventricular septal defect
– Free-wall rupture

• Right ventricular infarction
• Severe depression of
cardiac contractility
– Sepsis
– Myocarditis

• Mechanical obstruction to
forward blood flow
– Aortic stenosis
– Hypertrophic cardiomyopathy
– Mitral stenosis

• Regurgitation of left
ventricular output
– Chordal rupture
– Acute aortic insufficiency
Management
• Intra- aortic balloon pump
• Emergency cardiac revascularisation
• Airway ( endotracheal intubation, positive pressure )
• Acute myocardial infarction –aspirin, heparin
• Hypotension managed by small fluid challenge ( NS 100
to 250 ml )
• Vasoconstrictors ( dopamine , dobutamine)
• Phosphodiesterase inhibitor ( amrinone , milrinone )
combined with dopamine or dobutamine
•
Septic shock
• Sepsis is a heterogeneous clinical syndrome
that can be caused by any class of
microorganism. Although gram-negative and
gram-positive bacteria account for most sepsis
cases, fungi, mycobacteria, rickettsia, viruses,
or protozoans can cause similar presentations
•

Infection = microbial phenomenon characterized by an inflammatory response to the presence of
microorganisms or the invasion of normally sterile host tissue by those organisms.

•

Bacteremia = the presence of viable bacteria in the blood.

•

Systemic inflammatory response syndrome = the systemic inflammatory response to a variety of
severe clinical insults. The response is manifested by two or more of the following conditions: (1)
temperature >38°C or <36°C; (2) heart rate >90 beats/min; (3) respiratory rate >20 breaths/min or
PaCO2 <32 mm Hg; and (4) white blood cell count >12,000/ L, <4000/ L, or >10% immature (band)
forms.

•

Sepsis = the systemic response to infection, manifested by two or more of the following conditions
as a result of infection: (1) temperature >38°C or <36°C; (2) heart rate >90 beats/min; (3)
respiratory rate >20 breaths/min or PaCO2 <32 mm Hg; and (4) white blood cell count >12,000/ L,
<4000/ L, or >10% immature (band) forms.

•

Severe sepsis = sepsis associated with organ dysfunction, hypoperfusion, or hypotension.
Hypoperfusion and perfusion abnormalities may include, but are not limited to lactic acidosis,
oliguria, or an acute alteration in mental status.

•

Septic shock = sepsis-induced hypotension despite adequate fluid resuscitation along with the
presence of perfusion abnormalities that may include, but are not limited to, lactic acidosis,
oliguria, or an acute alteration in mental status. Patients who are receiving inotropic or vasopressor
agents may not be hypotensive at the time that perfusion abnormalities are measured.

•

Sepsis-induced hypotension = a systolic blood pressure <90 mm Hg or a reduction of 40 mm Hg
from baseline in the absence of other causes for hypotension.

•

Multiple organ dysfunction syndrome = presence of altered organ function in an acutely ill patient
such that homeostasis cannot be maintained without intervention.
Management
Anaphylactic shock
• Anaphylaxis is a severe systemic
hypersensitivity reaction characterized by
multisystem involvement, which may include
hypotension or airway compromise.
Anaphylaxis is a potentially life-threatening
cascade caused by the release of mediators
from mast cells and basophils in an IgEdependent fashion
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•

DRUGS
-Lactam antibiotics
Acetylsalicylic acid (ASA)
Trimethoprim-sulfamethoxazole
Vancomycin
Nonsteroidal anti-inflammatory drugs
(NSAIDs)
Virtually any drug
FOODS AND ADDITIVES
Shellfish
Soybeans
Nuts
Wheat
Milk
Eggs
Salicylates
Seeds
Sulfites

•
•
•
•
•

OTHERS
Hymenoptera stings
Insect parts and molds
Radiographic contrast material
Latex
Treatment
• Emergency treatment: rapid administration of
epinephrine
• First line treatment :
– ABC of resuscitation
– Epinephrine , intravenous fluids and oxygen

• second line treatment :
– Coticosteroids
– Anti histamines
– Agents for allergic bronchospasm ( magnesium
sulphate )
Neurogenic shock
• Neurogenic shock, characterized by
hypotension and bradycardia, occurs after an
acute spinal cord injury that disrupts
sympathetic outflow, leaving unopposed vagal
tone
Management

More Related Content

What's hot

What's hot (20)

Local control of blood flow
Local control of blood flow Local control of blood flow
Local control of blood flow
 
Shock for BS Medical technologist
Shock for BS Medical technologistShock for BS Medical technologist
Shock for BS Medical technologist
 
Shock
ShockShock
Shock
 
2 shock 1
2 shock 12 shock 1
2 shock 1
 
Mechanism of blood flow control. 2017
Mechanism of blood flow control. 2017Mechanism of blood flow control. 2017
Mechanism of blood flow control. 2017
 
shock
shock shock
shock
 
Pathophysiology of shock
Pathophysiology  of  shockPathophysiology  of  shock
Pathophysiology of shock
 
Septic shock Pathophysiology
Septic shock Pathophysiology Septic shock Pathophysiology
Septic shock Pathophysiology
 
Hemodynamic monitoring
Hemodynamic  monitoringHemodynamic  monitoring
Hemodynamic monitoring
 
Approach to Shock and Hemodynamics
Approach to Shock and HemodynamicsApproach to Shock and Hemodynamics
Approach to Shock and Hemodynamics
 
Perioperative hypoxia
Perioperative hypoxiaPerioperative hypoxia
Perioperative hypoxia
 
Shock
ShockShock
Shock
 
Lactate and cardiopulmonary bypass
Lactate and cardiopulmonary bypass Lactate and cardiopulmonary bypass
Lactate and cardiopulmonary bypass
 
Shock - Pathophysiology, Clinical Features & Management
Shock - Pathophysiology, Clinical Features & ManagementShock - Pathophysiology, Clinical Features & Management
Shock - Pathophysiology, Clinical Features & Management
 
Hypovolemic shock
Hypovolemic shockHypovolemic shock
Hypovolemic shock
 
02 shock
02 shock02 shock
02 shock
 
Pulsatile vs non pulsatile perfusion
Pulsatile vs non pulsatile perfusionPulsatile vs non pulsatile perfusion
Pulsatile vs non pulsatile perfusion
 
Shock
Shock Shock
Shock
 
Hypotension management in ICU, volume vessel or pump?
Hypotension  management in ICU, volume vessel or pump?Hypotension  management in ICU, volume vessel or pump?
Hypotension management in ICU, volume vessel or pump?
 
Shock its types and management
Shock its types and managementShock its types and management
Shock its types and management
 

Similar to 8shock

shock surgery -bailey and love
 shock surgery  -bailey and love shock surgery  -bailey and love
shock surgery -bailey and love
DivyaBhati11
 
Pathophysiology of shock
Pathophysiology of shockPathophysiology of shock
Pathophysiology of shock
Yogesh Ramasamy
 

Similar to 8shock (20)

1011shock-161227090739.pdf
1011shock-161227090739.pdf1011shock-161227090739.pdf
1011shock-161227090739.pdf
 
10 &amp;11 shock
10 &amp;11 shock10 &amp;11 shock
10 &amp;11 shock
 
circulatory shock.pptx
circulatory shock.pptxcirculatory shock.pptx
circulatory shock.pptx
 
Managament of Shock
Managament of ShockManagament of Shock
Managament of Shock
 
Shock , surgery4121952433713521989
Shock , surgery4121952433713521989Shock , surgery4121952433713521989
Shock , surgery4121952433713521989
 
Types of Shock
Types of Shock Types of Shock
Types of Shock
 
Pathophysiology of shock and its management
Pathophysiology of shock and its managementPathophysiology of shock and its management
Pathophysiology of shock and its management
 
Management of Shock
Management of ShockManagement of Shock
Management of Shock
 
Shock
ShockShock
Shock
 
Shock
ShockShock
Shock
 
shock surgery -bailey and love
 shock surgery  -bailey and love shock surgery  -bailey and love
shock surgery -bailey and love
 
Shock
ShockShock
Shock
 
Pathophysiology of shock
Pathophysiology of shockPathophysiology of shock
Pathophysiology of shock
 
shock and its management copy
shock and its management   copyshock and its management   copy
shock and its management copy
 
Shock.pptx
Shock.pptxShock.pptx
Shock.pptx
 
Shock in Trauma Patient by Dr. Sabbir.pptx
Shock in Trauma Patient by Dr. Sabbir.pptxShock in Trauma Patient by Dr. Sabbir.pptx
Shock in Trauma Patient by Dr. Sabbir.pptx
 
Shock.pptx
Shock.pptxShock.pptx
Shock.pptx
 
SHOCK .pptx
SHOCK .pptxSHOCK .pptx
SHOCK .pptx
 
SHOCK AND HAEMORRHAGE.pdf
SHOCK AND HAEMORRHAGE.pdfSHOCK AND HAEMORRHAGE.pdf
SHOCK AND HAEMORRHAGE.pdf
 
Shock.pptx
Shock.pptxShock.pptx
Shock.pptx
 

More from Gyanendra Raj Joshi (20)

B pharm syllabus pu
B pharm syllabus puB pharm syllabus pu
B pharm syllabus pu
 
14drugs acting on respiratory system expectorants, respiratory stimulants
14drugs acting on respiratory system  expectorants, respiratory stimulants14drugs acting on respiratory system  expectorants, respiratory stimulants
14drugs acting on respiratory system expectorants, respiratory stimulants
 
13drugs acting on respiratory system anti asthmatics
13drugs acting on respiratory system   anti asthmatics13drugs acting on respiratory system   anti asthmatics
13drugs acting on respiratory system anti asthmatics
 
12anticoagulants
12anticoagulants12anticoagulants
12anticoagulants
 
11hematinics
11hematinics11hematinics
11hematinics
 
10 anemia
10 anemia10 anemia
10 anemia
 
9autacoids
9autacoids9autacoids
9autacoids
 
7 fluid, electrolyte balance
7 fluid, electrolyte balance7 fluid, electrolyte balance
7 fluid, electrolyte balance
 
6anti hyperlipidemic drugs
6anti hyperlipidemic drugs6anti hyperlipidemic drugs
6anti hyperlipidemic drugs
 
5diuretics class
5diuretics class5diuretics class
5diuretics class
 
3arrythmia pharmacotherapy
3arrythmia pharmacotherapy3arrythmia pharmacotherapy
3arrythmia pharmacotherapy
 
2cardiac arrhytmia
2cardiac arrhytmia2cardiac arrhytmia
2cardiac arrhytmia
 
1 drugs acting on cardiovascular system
1 drugs acting on cardiovascular system1 drugs acting on cardiovascular system
1 drugs acting on cardiovascular system
 
4 chf
4 chf4 chf
4 chf
 
Pharmacology microsyllabus
Pharmacology microsyllabusPharmacology microsyllabus
Pharmacology microsyllabus
 
Drug information resources
Drug  information resourcesDrug  information resources
Drug information resources
 
Pharmacogenetics
PharmacogeneticsPharmacogenetics
Pharmacogenetics
 
Lecture pharmacology of calcium metabolism
Lecture pharmacology of calcium metabolismLecture pharmacology of calcium metabolism
Lecture pharmacology of calcium metabolism
 
Lecture 1 anti viral agents
Lecture 1 anti viral agentsLecture 1 anti viral agents
Lecture 1 anti viral agents
 
Drugs affecting thrombosis
Drugs affecting thrombosisDrugs affecting thrombosis
Drugs affecting thrombosis
 

8shock

  • 2. • Shock is defined as circulatory insufficiency that creates an imbalance between tissue oxygen supply and oxygen demand. • The result of shock is global tissue hypoperfusion and is associated with a decreased venous oxygen content and metabolic acidosis (lactic acidosis). • Clinically, shock may have a predominant cause, but as the shock state persists or progresses to irreversible end organ damage, other pathophysiologic mechanisms become operative
  • 3. • Shock is classified into four categories by etiology (1) hypovolemic (caused by inadequate circulating volume) (2) cardiogenic (caused by inadequate cardiac pump function) (3) distributive (caused by peripheral vasodilatation and maldistribution of blood flow) (4) obstructive (caused by extra cardiac obstruction to blood flow).
  • 4. Pathophysiology • The onset of shock -- autonomic responses, many of which serve to maintain perfusion pressure to vital organs. • Stimulation of the carotid baroreceptor stretch reflex activates the sympathetic nervous system leading to: • (1) arteriolar vasoconstriction, resulting in redistribution of blood flow from the skin, skeletal muscle, kidneys, and splanchnic viscera; • (2) an increase in heart rate and contractility that increases cardiac output; • (3) constriction of venous capacitance vessels, which augments venous return; • (4) release of the vasoactive hormones epinephrine, norepinephrine, dopamine, and cortisol to increase arteriolar and venous tone; and • (5) release of antidiuretic hormone and activation of the reninangiotensin axis to enhance water and sodium conservation to maintain intravascular volume. • These compensatory mechanisms attempt to maintain DO2 to the most critical organs—the coronary and cerebral circulation. During this process, blood flow to other organs such as the kidneys and gastrointestinal tract may be compromised.
  • 5. • In the early phases of septic shock, these physiologic changes produce a clinical syndrome called the systemic inflammatory response syndrome or SIRS, defined as the presence of two or more of the following features: • (1) temperature greater than 38°C (100.4°F) or less than 36°C (96.8°F); • (2) heart rate faster than 90 beats/min; • (3) respiratory rate faster than 20 breaths/min; and • (4) white blood cell count greater than 12.0 x 109/L, less than 4.0 x 109/L, or with greater than 10 percent immature forms or bands. • 5) As SIRS progresses, shock ensues, followed by multiorgan dysfunction syndrome (MODS) manifested by myocardial depression, adult respiratory distress syndrome, disseminated intravascular coagulation, hepatic failure, or renal failure. • The fulminate progression from SIRS to MODS is determined by the balance of anti-inflammatory and proinflammatory mediators or cytokines that are released from endothelial cell disruption
  • 6. • The cellular response to decreased DO2 ( oxygen delivery per minute ) is adenosine triphosphate depletion leading to ion-pump dysfunction, influx of sodium, efflux of potassium, and reduction in membrane resting potential. Cellular edema occurs secondary to increased intracellular sodium, while cellular membrane receptors become poorly responsive to the stress hormones insulin, glucagon, cortisol, and catecholamines. As shock progresses, lysosomal enzymes are released into the cells with subsequent hydrolysis of membranes, deoxyribonucleic acid, ribonucleic acid, and phosphate esters. As the cascade of shock continues, the loss of cellular integrity and the breakdown in cellular homeostasis result in cellular death. These pathologic events give rise to the metabolic features of hemoconcentration, hyperkalemia, hyponatremia, prerenal azotemia, hyper- or hypoglycemia, and lactic acidosis.
  • 7.
  • 8. ABCDE tenets of shock resuscitation • • • • • establishing Airway controlling the work of Breathing optimizing the Circulation assuring adequate oxygen Delivery, and achieving End points of resuscitation
  • 9. Establishing Airway • Airway control is best obtained through endotracheal intubation for airway protection, positive pressure ventilation (oxygenation), and pulmonary toilet. Sedatives, which are frequently used to facilitate intubation, can exacerbate hypotension through arterial vasodilatation, venodilation, and myocardial suppression. Furthermore, positive pressure ventilation reduces preload and cardiac output. The combination of these interventions can lead to hemodynamic collapse. Volume resuscitation or application of vasoactive agents may be required prior to intubation and positive pressure ventilation.
  • 10. Controlling the Work of Breathing • Control of breathing is required when tachypnea accompanies shock. Respiratory muscles are significant consumers of oxygen during shock and contribute to lactate production. Mechanical ventilation and sedation decrease the work of breathing and have been shown to improve survival. SaO2 should be restored to greater than 93 percent and ventilation controlled to maintain a PaCO2 35 to 40 mm Hg. Attempts to normalize pH above 7.3 by hyperventilation are not beneficial. Mechanical ventilation not only provides oxygenation and corrects hypercapnia but assists, controls, and synchronizes ventilation, which ultimately decreases the work of breathing. Neuromuscular blocking agents are used as adjuncts to further decrease respiratory muscle, oxygen consumption and preserve DO2 to vital organs
  • 11. Optimizing the Circulation • Circulatory or hemodynamic stabilization begins with intravascular access through large-bore peripheral venous lines. Trendelenburg positioning, historically considered necessary for maintaining perfusion in the hypotensive patient, does not improve cardiopulmonary performance compared with the supine position. It may worsen pulmonary gas exchange and predispose to aspiration. If a volume challenge is urgently required, rather than using the Trendelenburg position, an alternative is to raise the patient's legs above the level of the heart with the patient supine. • Fluid resuscitation begins with isotonic crystalloid; the amount and rate are determined by an estimate of the hemodynamic abnormality. Most patients in shock have either an absolute or relative volume deficit, except the patient in cardiogenic shock with pulmonary edema • Vasopressor agents are used when there has been an inadequate response to volume resuscitation or when a patient has contraindications to volume infusion
  • 12.
  • 13.
  • 14. Assuring Adequate Oxygen Delivery • Once blood pressure is stabilized through optimization of preload and afterload, DO2 can be assessed and further manipulated. Arterial oxygen saturation should be returned to physiologic levels (93 to 95 percent) and hemoglobin maintained above 10 g/dL.13 If cardiac output can be assessed, it should be increased by using volume infusion and inotropic agents in incremental amounts until venous oxygen saturation (SmvO2 or ScvO2) and lactate are normalized.
  • 15. Achieving End Points of Resuscitation
  • 16. Hypovolemic shock • • 2 types Hemorrhagic hypovolemia – – – – – – – – – – – – – Thorax Pulmonary parenchymal trauma Pulmonary vascular injury Intercostal vascular injury Aortic disruption Massive hemoptysis Abdomen/pelvis/retroperitoneum Solid organ injuries (liver, spleen, kidney) Vascular (trauma, aneurysmal rupture) Gastrointestinal hemorrhage (esophageal varices, ulcers, vascular anomalies, etc.) Gynecologic disorders (ruptured ectopic pregnancy, peripartum hemorrhage, abnormal uterine bleeding, ovarian cyst rupture, etc.) Major vascular injuries Large soft tissue injuries • Non hemorrhagic hypovolemia • Gastrointestinal disorders: vomiting, diarrhea, ascites • Burns • Environmental exposure or neglect • Renal salt wasting
  • 17. Resuscitation Fluids • Isotonic crystalloid – Normal saline (NS) – Lactated Ringer's (LR) solution – Ringer's acetate • Colloids – Albumin: 5% and 25% concentrations – Fresh-frozen plasma – Hetastarch: 6% hydroxyethyl starch concentration – Dextran -40 (molecular weight 40 kDa) 10% solution – Dextran -70 (molecular weight 70 kDa) 6% solution – Gelatin • Hypertonic solutions – Saline: 7.0 to 7.5% NaCl – Saline and dextran: 7.5% NaCl and 6% Dextran-70 • Oxygen carrying resuscitation fluids – Hemoglobin-based oxygen carriers – Fluorocarbon-based oxygen carriers • Blood – Packed red blood cells
  • 18. Cardiogenic shock • Cardiogenic shock is defined as a state of decreased cardiac output (CO) producing inadequate tissue perfusion despite adequate or excessive circulating volume. • Clinical signs of cardiogenic shock include evidence of poor CO with tissue hypoperfusion (hypotension, mental status changes, cool mottled skin) and evidence of volume overload (dyspnea,
  • 19. Causes • Acute myocardial infarction • Pump failure – Mechanical complications – Acute mitral regurgitation secondary to papillary muscle rupture – Ventricular septal defect – Free-wall rupture • Right ventricular infarction • Severe depression of cardiac contractility – Sepsis – Myocarditis • Mechanical obstruction to forward blood flow – Aortic stenosis – Hypertrophic cardiomyopathy – Mitral stenosis • Regurgitation of left ventricular output – Chordal rupture – Acute aortic insufficiency
  • 20. Management • Intra- aortic balloon pump • Emergency cardiac revascularisation • Airway ( endotracheal intubation, positive pressure ) • Acute myocardial infarction –aspirin, heparin • Hypotension managed by small fluid challenge ( NS 100 to 250 ml ) • Vasoconstrictors ( dopamine , dobutamine) • Phosphodiesterase inhibitor ( amrinone , milrinone ) combined with dopamine or dobutamine •
  • 21.
  • 22. Septic shock • Sepsis is a heterogeneous clinical syndrome that can be caused by any class of microorganism. Although gram-negative and gram-positive bacteria account for most sepsis cases, fungi, mycobacteria, rickettsia, viruses, or protozoans can cause similar presentations
  • 23. • Infection = microbial phenomenon characterized by an inflammatory response to the presence of microorganisms or the invasion of normally sterile host tissue by those organisms. • Bacteremia = the presence of viable bacteria in the blood. • Systemic inflammatory response syndrome = the systemic inflammatory response to a variety of severe clinical insults. The response is manifested by two or more of the following conditions: (1) temperature >38°C or <36°C; (2) heart rate >90 beats/min; (3) respiratory rate >20 breaths/min or PaCO2 <32 mm Hg; and (4) white blood cell count >12,000/ L, <4000/ L, or >10% immature (band) forms. • Sepsis = the systemic response to infection, manifested by two or more of the following conditions as a result of infection: (1) temperature >38°C or <36°C; (2) heart rate >90 beats/min; (3) respiratory rate >20 breaths/min or PaCO2 <32 mm Hg; and (4) white blood cell count >12,000/ L, <4000/ L, or >10% immature (band) forms. • Severe sepsis = sepsis associated with organ dysfunction, hypoperfusion, or hypotension. Hypoperfusion and perfusion abnormalities may include, but are not limited to lactic acidosis, oliguria, or an acute alteration in mental status. • Septic shock = sepsis-induced hypotension despite adequate fluid resuscitation along with the presence of perfusion abnormalities that may include, but are not limited to, lactic acidosis, oliguria, or an acute alteration in mental status. Patients who are receiving inotropic or vasopressor agents may not be hypotensive at the time that perfusion abnormalities are measured. • Sepsis-induced hypotension = a systolic blood pressure <90 mm Hg or a reduction of 40 mm Hg from baseline in the absence of other causes for hypotension. • Multiple organ dysfunction syndrome = presence of altered organ function in an acutely ill patient such that homeostasis cannot be maintained without intervention.
  • 25. Anaphylactic shock • Anaphylaxis is a severe systemic hypersensitivity reaction characterized by multisystem involvement, which may include hypotension or airway compromise. Anaphylaxis is a potentially life-threatening cascade caused by the release of mediators from mast cells and basophils in an IgEdependent fashion
  • 26. • • • • • • • • • • • • • • • • • DRUGS -Lactam antibiotics Acetylsalicylic acid (ASA) Trimethoprim-sulfamethoxazole Vancomycin Nonsteroidal anti-inflammatory drugs (NSAIDs) Virtually any drug FOODS AND ADDITIVES Shellfish Soybeans Nuts Wheat Milk Eggs Salicylates Seeds Sulfites • • • • • OTHERS Hymenoptera stings Insect parts and molds Radiographic contrast material Latex
  • 27. Treatment • Emergency treatment: rapid administration of epinephrine • First line treatment : – ABC of resuscitation – Epinephrine , intravenous fluids and oxygen • second line treatment : – Coticosteroids – Anti histamines – Agents for allergic bronchospasm ( magnesium sulphate )
  • 28.
  • 29.
  • 30. Neurogenic shock • Neurogenic shock, characterized by hypotension and bradycardia, occurs after an acute spinal cord injury that disrupts sympathetic outflow, leaving unopposed vagal tone